MYX 2.49% $4.69 mayne pharma group limited

MYX valuation

  1. 1,969 Posts.
    lightbulb Created with Sketch. 8
    Just did some numbers, any thoughts ppl? It's high level but gives a view? Feedback appreciated. Cheers.

    **

    Acquisiton revenue,
    US$237m = A$300m @ FX 0.80 (conservative)

    NPAT margin 9-15%
    (Based on H1 release for H1'14 & H1'15)
    Not precise but gives an OK range.

    Acquisition therefore gives about,
    NPAT extra for FY17 - A$27m-$45m. Upside to A$55m?

    We know,

    H1'16 result = A$20m
    H2'16 result? = Let's say A$25-30m range

    So, FY17.

    Acquisition: A$27-45m Upside to A$55m

    Existing biz: FY16 of A$45-50 with 5-10% growth. FY17 A$47-$55m

    Current MC: A$3.09bn

    FY 17 -> Add the two to get estimate, PE shown are based on current MC and FY17s

    Lower end: FY17 NPAT A$74m, PE 40
    Mid est:. FY17: NPAT A$92m, PE 33
    Upper end: FY17: NPAT A$110m, PE 27
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.69
Change
-0.120(2.49%)
Mkt cap ! $403.2M
Open High Low Value Volume
$4.79 $4.79 $4.64 $86.34K 18.40K

Buyers (Bids)

No. Vol. Price($)
4 2107 $4.67
 

Sellers (Offers)

Price($) Vol. No.
$4.69 1022 12
View Market Depth
Last trade - 13.29pm 13/09/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.